Results 301 to 305 of about 25,541,282 (305)

Improved survival, disparate outcomes contemporaneously define the modern worldwide burden of childhood cancers

Ca-A Cancer Journal for Clinicians
Matthew Kudek
exaly  

Survival Analysis

2018
openaire   +2 more sources

Data support longer recurrence-free survival with nivolumab than with ipilimumab for stage III or IV melanoma

Ca-A Cancer Journal for Clinicians
exaly  

Survival Analysis

2009
openaire   +1 more source

Survival Analysis

openaire   +1 more source